Improving access to quality medicines

CuraTeQ’s end-to-end biosimilar production facility is a fully equipped 40,000 sq. ft. commercial scale manufacturing and R&D centre, with dedicated laboratories to support all biosimilar research and development, production and quality control activities.

Biosimilar production requires a strong research and development footprint and expert scientific resources. Our production centre in Hyderabad, India has end-to-end capabilities for producing a full range of products from bulk drug substance (DS) to fill-finish and packaged drug products (DP).

The Quality Control Laboratories at our production centre are engaged in all physicochemical, analytical and microbiological analyses involved in the verification and testing of biological products and are instrumental in undertaking method transfer, compendial method verification and method validation activities. Biosimilar research and development requires a strong research and development footprint and expert scientific resources.